Key opinion leaders on GLP-1 receptor agonist clinical trial design
There are more than 50 glucagon-like peptide-1 receptor agonists (GLP-1RAs) in clinical development for Type 2 diabetes, obesity, or both.…
There are more than 50 glucagon-like peptide-1 receptor agonists (GLP-1RAs) in clinical development for Type 2 diabetes, obesity, or both.…
Syphilis, the sexually transmitted infection (STI) that was once near elimination in the US, is now increasing at an exponential…
World Immunization Week occurs annually during the last week of April. The campaign aims to highlight the collective action needed…
At this year’s World Congress of Nephrology, positive results were presented from Novartis’s pre-specified interim analysis of the Phase III…
Postpartum depression (PPD) is depression lasting more than two weeks postpartum, and is characterised by feelings of hopelessness, anger, guilt,…
At the American Academy of Neurology (AAN) 2024 Annual Meeting, during the Neurology Year in Review Plenary Session, the safety…
At the American Academy of Neurology (AAN) 2024 Annual Meeting, Pharma Two B presented new safety and tolerability data for…
A key theme from the spinal muscular atrophy (SMA) presentations at the American Academy of Neurology (AAN) 2024 Annual Meeting…
Lung cancer is the leading cause of cancer death around the world, with an estimated 2.2 million new cases and…
There are currently no marketed disease-modifying therapies (DMTs) for Parkinson’s disease (PD). Key opinion leaders (KOLs) previously interviewed by GlobalData,…